Benign Neonatal Seizures

Mendelian MONDO:0016027 Pathograph 9 Epilepsy

Benign neonatal seizures (also known as benign familial neonatal seizures / convulsions, BFNS/BFNC, and now classified by ILAE as self-limited (familial) neonatal epilepsy) is an autosomal dominant focal epilepsy syndrome of the newborn. Seizures typically begin within the first week of life in otherwise healthy term infants and remit spontaneously within months to the first year. The condition is caused most often by heterozygous loss-of-function variants in KCNQ2 (chromosome 20q13) and less commonly KCNQ3 (chromosome 8q24), which encode voltage-gated potassium channel subunits that heteromultimerize to form the neuronal M-channel. Reduced M-current attenuates subthreshold potassium conductance and produces a mild, developmentally transient neuronal hyperexcitability that resolves as the brain matures. Long-term neurodevelopment is generally normal. Benign familial neonatal seizures are clinically and mechanistically distinct from KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE), which arises from more severe (typically dominant-negative) KCNQ2 variants.

Ask OpenScientist

Ask a research question about Benign Neonatal Seizures. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
1
Inheritance
2
Pathophys.
11
Phenotypes
9
Pathograph
2
Genes
2
Treatments
2
Subtypes
1
Deep Research
🔗

Mappings

MONDO
MONDO:0016027 benign neonatal seizures
skos:exactMatch Orphanet ORPHA:1949: CONSISTENT
Orphanet ORPHA:1949 (self-limited neonatal epilepsy) lists MONDO:0016027 as an exact cross-reference.
👪

Inheritance

1
Autosomal dominant HP:0000006
Benign familial neonatal seizures segregate in an autosomal dominant manner in multigenerational families with heterozygous KCNQ2 or KCNQ3 variants.
Autosomal dominant inheritance
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"Autosomal dominant"
Orphanet directly lists autosomal dominant inheritance for ORPHA:1949.
PMID:9425895 SUPPORT Human Clinical
"One type is benign familial neonatal convulsions (BFNC), a dominantly inherited disorder of newborns."
The original KCNQ2 discovery paper characterizes BFNC as a dominantly inherited disorder of newborns.
◆

Subtypes

2
KCNQ2-related benign familial neonatal seizures MONDO:0007365
The more common molecular subtype, caused by heterozygous loss-of-function variants in KCNQ2 on chromosome 20q13.3. Distinct from the more severe KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE).
Show evidence (2 references)
PMID:9425895 SUPPORT Human Clinical
"We have identified a sub-microscopic deletion of chromosome 20q13.3 that co-segregates with seizures in a BFNC family."
Singh et al. 1998 maps the KCNQ2-BFNC locus to chromosome 20q13.3.
ORPHA:1949 SUPPORT Other
"KCNQ2 | potassium voltage-gated channel subfamily Q member 2 | hgnc:6296 | Disease-causing germline mutation(s) in"
Orphanet identifies KCNQ2 as a disease-causing gene for self-limited neonatal epilepsy.
KCNQ3-related benign familial neonatal seizures MONDO:0007366
The less common molecular subtype, caused by heterozygous variants in KCNQ3 on chromosome 8q24.
Show evidence (2 references)
PMID:9425900 SUPPORT Human Clinical
"We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
Charlier et al. 1998 identifies a KCNQ3 pore-region missense variant co-segregating with BFNC.
ORPHA:1949 SUPPORT Other
"KCNQ3 | potassium voltage-gated channel subfamily Q member 3 | hgnc:6297 | Disease-causing germline mutation(s) in"
Orphanet identifies KCNQ3 as a disease-causing gene for self-limited neonatal epilepsy.
⚙

Pathophysiology

2
KCNQ2/KCNQ3 K+ Channel Loss-of-Function and M-Current Attenuation
KCNQ2 (Kv7.2) and KCNQ3 (Kv7.3) subunits heteromultimerize to form the neuronal M-channel, a voltage-gated potassium channel that carries the slowly activating, non-inactivating M-current. The M-current acts in the subthreshold voltage range to dampen repetitive firing and constrain neuronal excitability. Heterozygous loss-of-function variants in KCNQ2 or KCNQ3 reduce M-current density.
neuron link pyramidal neuron link
KCNQ2 link KCNQ3 link
membrane repolarization link ↓ DECREASED
voltage-gated potassium channel activity link ↓ DECREASED
cerebral cortex link
Downstream
Neonatal Neuronal Hyperexcitability Reduced M-current decreases subthreshold K+ conductance and lowers the threshold for repetitive firing in neonatal cortical neurons, producing transient network hyperexcitability.
Show evidence (3 references)
PMID:9836639 SUPPORT In Vitro
"It is concluded that both these subunits contribute to the native M-current."
Wang et al. 1998 directly demonstrates that KCNQ2 and KCNQ3 subunits constitute the M-channel.
PMID:9836639 SUPPORT In Vitro
"The M-current regulates the subthreshold electrical excitability of many neurons, determining their firing properties and responsiveness to synaptic input."
Establishes the role of the KCNQ2/3-mediated M-current in regulating subthreshold neuronal excitability.
PMID:9425895 SUPPORT Human Clinical
"This finding in BFNC provides additional evidence that defects in potassium channels are involved in the mammalian epilepsy phenotype."
The original KCNQ2-BFNC paper directly attributes the phenotype to potassium-channel dysfunction.
Neonatal Neuronal Hyperexcitability
Reduced M-current produces a mild, developmentally restricted state of cortical hyperexcitability that manifests as focal neonatal seizures. Because compensatory potassium conductances and inhibitory circuits mature over the first months of life, the hyperexcitability is transient and seizures spontaneously remit, distinguishing this benign phenotype from KCNQ2-related developmental and epileptic encephalopathy.
neuron link pyramidal neuron link
neuronal action potential link ↑ INCREASED
cerebral cortex link
Downstream
Focal-onset seizures Network-level hyperexcitability manifests as focal neonatal seizures.
Show evidence (1 reference)
PMID:36939707 SUPPORT Human Clinical
"Seizures tend to remit during infancy or early childhood and are therefore called "self-limited"."
The ILAE review confirms the transient, age-limited nature of the seizure phenotype.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Referential integrity issues (1):
  • Target 'Focal-onset seizures' (from 'Neonatal Neuronal Hyperexcitability') not found in named elements
Pathograph: causal mechanism network for Benign Neonatal Seizures Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

11
Nervous System 1
Focal-onset Seizure VERY_FREQUENT Focal-onset seizure (HP:0007359)
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0007359 | Focal-onset seizure | Very frequent (99-80%)"
Orphanet's curated HPO table classifies focal-onset seizures as very frequent.
Respiratory 1
Apnea FREQUENT Apnea (HP:0002104)
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"HP:0002104 | Apnea | Frequent (79-30%)"
Orphanet's curated HPO table classifies apnea as frequent.
PMID:28926830 SUPPORT Human Clinical
"Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation."
KCNQ2 case series documents ictal apnea as a recurrent feature.
Other 9
Neonatal Seizure VERY_FREQUENT Neonatal seizure (HP:0032807)
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"HP:0032807 | Neonatal seizure | Very frequent (99-80%)"
Orphanet's curated HPO table classifies neonatal seizures as very frequent.
PMID:36939707 SUPPORT Human Clinical
"autosomal dominant disorders characterized by neonatal- or infantile-onset focal motor seizures and the absence of neurodevelopmental complications."
ILAE review supports neonatal-onset focal motor seizures as the defining feature.
Focal Tonic Seizure VERY_FREQUENT Focal tonic seizure (HP:0011167)
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"HP:0011167 | Focal tonic seizure | Very frequent (99-80%)"
Orphanet's curated HPO table classifies focal tonic seizures as very frequent.
PMID:28926830 SUPPORT Human Clinical
"Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation."
KCNQ2 case series describes characteristic tonic seizures with apnea/desaturation.
Focal Clonic Seizure VERY_FREQUENT Focal clonic seizure (HP:0002266)
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0002266 | Focal clonic seizure | Very frequent (99-80%)"
Orphanet's curated HPO table classifies focal clonic seizures as very frequent.
Clonus FREQUENT Clonus (HP:0002169)
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0002169 | Clonus | Frequent (79-30%)"
Orphanet's curated HPO table classifies clonus as frequent.
Generalized Tonic Seizure FREQUENT Generalized tonic seizure (HP:0010818)
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0010818 | Generalized tonic seizure | Frequent (79-30%)"
Orphanet's curated HPO table classifies generalized tonic seizures as frequent.
Focal Autonomic Seizure FREQUENT Focal autonomic seizure (HP:0011154)
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0011154 | Focal autonomic seizure | Frequent (79-30%)"
Orphanet's curated HPO table classifies focal autonomic seizures as frequent.
Circumoral Cyanosis FREQUENT Circumoral cyanosis (HP:0032556)
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0032556 | Circumoral cyanosis | Frequent (79-30%)"
Orphanet's curated HPO table classifies circumoral cyanosis as frequent.
Limb Myoclonus FREQUENT Limb myoclonus (HP:0045084)
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0045084 | Limb myoclonus | Frequent (79-30%)"
Orphanet's curated HPO table classifies limb myoclonus as frequent.
Focal EEG Discharges with Secondary Generalization VERY_FREQUENT Focal EEG discharges with secondary generalization (HP:0011188)
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0011188 | Focal EEG discharges with secondary generalization | Very frequent (99-80%)"
Orphanet's curated HPO table classifies this EEG pattern as very frequent.
🧬

Genetic Associations

2
KCNQ2 (Causal loss-of-function variant)
Autosomal dominant with incomplete penetrance
Show evidence (2 references)
PMID:9425895 SUPPORT Human Clinical
"Five other BFNC probands were shown to have KCNQ2 mutations, including two transmembrane missense mutations, two frameshifts and one splice-site mutation."
Singh et al. 1998 established KCNQ2 as the major causal gene for benign familial neonatal convulsions.
ORPHA:1949 SUPPORT Other
"KCNQ2 | potassium voltage-gated channel subfamily Q member 2 | hgnc:6296 | Disease-causing germline mutation(s) in"
Orphanet gene table confirms KCNQ2 as a disease-causing gene.
KCNQ3 (Causal loss-of-function variant)
Autosomal dominant with incomplete penetrance
Show evidence (2 references)
PMID:9425900 SUPPORT Human Clinical
"We screened KCNQ3 for mutations in the large BFNC family previously linked to chromosome 8q24 in the same marker interval. We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
Charlier et al. 1998 established KCNQ3 as a causal BFNC gene.
ORPHA:1949 SUPPORT Other
"KCNQ3 | potassium voltage-gated channel subfamily Q member 3 | hgnc:6297 | Disease-causing germline mutation(s) in"
Orphanet gene table confirms KCNQ3 as a disease-causing gene.
💊

Treatments

2
Carbamazepine
Action: anticonvulsant agent therapy MAXO:0000167
Agent: carbamazepine ↗
Carbamazepine, a sodium-channel-blocking antiseizure medication, is effective for KCNQ2/KCNQ3-related neonatal seizures and is recommended as first- or second-line targeted therapy in this group.
Mechanism Target:
INHIBITS Neonatal Neuronal Hyperexcitability — Sodium-channel blockade by carbamazepine attenuates the action-potential bursting that arises from reduced M-current and aborts focal neonatal seizures.
Show evidence (1 reference)
PMID:37827512 SUPPORT Human Clinical
"Carbamazepine (CBZ) is effective in treating KCNQ2/3-related seizures, which may present with a distinctive amplitude-integrated electroencephalography (aEEG) pattern."
Case-series evidence supports carbamazepine as effective targeted therapy for KCNQ2/3 neonatal seizures.
Target Phenotypes: Neonatal seizure ↗ Focal-onset seizure ↗
Show evidence (2 references)
PMID:37827512 SUPPORT Human Clinical
"prompted the use of CBZ that was effective in all."
Carbamazepine was effective in all four neonates given the targeted therapy in this case series.
PMID:28926830 SUPPORT Human Clinical
"Prompt recognition of this pattern led to early treatment with carbamazepine in the 2 most recent cases."
Earlier KCNQ2 case series also supports carbamazepine as targeted therapy.
Sodium-channel-blocking Antiseizure Medication Therapy
Action: anticonvulsant agent therapy MAXO:0000167
Sodium-channel blockers as a class (e.g., carbamazepine, oxcarbazepine, phenytoin) are favored over phenobarbital for KCNQ2/KCNQ3-related neonatal seizures based on a precision-medicine approach.
Target Phenotypes: Neonatal seizure ↗
Show evidence (1 reference)
PMID:28926830 SUPPORT Human Clinical
"Early recognition of the electroclinical phenotype by using aEEG may direct genetic testing and a precision medicine approach with sodium channel blockers in neonates with KCNQ2 mutations."
The case series explicitly recommends sodium-channel blockers as targeted precision therapy in KCNQ2 neonatal epilepsy.
{ }

Source YAML

click to show 
name: Benign Neonatal Seizures
creation_date: "2026-05-13T12:00:00Z"
updated_date: "2026-05-13T20:00:00Z"
category: Mendelian
description: >-
  Benign neonatal seizures (also known as benign familial neonatal seizures /
  convulsions, BFNS/BFNC, and now classified by ILAE as self-limited (familial)
  neonatal epilepsy) is an autosomal dominant focal epilepsy syndrome of the
  newborn. Seizures typically begin within the first week of life in otherwise
  healthy term infants and remit spontaneously within months to the first year.
  The condition is caused most often by heterozygous loss-of-function variants
  in KCNQ2 (chromosome 20q13) and less commonly KCNQ3 (chromosome 8q24), which
  encode voltage-gated potassium channel subunits that heteromultimerize to
  form the neuronal M-channel. Reduced M-current attenuates subthreshold
  potassium conductance and produces a mild, developmentally transient
  neuronal hyperexcitability that resolves as the brain matures. Long-term
  neurodevelopment is generally normal. Benign familial neonatal seizures are
  clinically and mechanistically distinct from KCNQ2-related developmental and
  epileptic encephalopathy (KCNQ2-DEE), which arises from more severe
  (typically dominant-negative) KCNQ2 variants.
disease_term:
  preferred_term: benign neonatal seizures
  term:
    id: MONDO:0016027
    label: benign neonatal seizures
synonyms:
- Benign familial neonatal seizures
- Benign familial neonatal convulsions
- Benign familial neonatal epilepsy
- Self-limited familial neonatal epilepsy
- BFNS
- BFNC
- SeLNE
parents:
- Epilepsy
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0016027
      label: benign neonatal seizures
    mapping_predicate: skos:exactMatch
    mapping_source: Orphanet
    mapping_justification: Orphanet ORPHA:1949 (self-limited neonatal epilepsy) lists MONDO:0016027 as an exact cross-reference.
    consistency:
    - reference: ORPHA:1949
      consistent: CONSISTENT
      notes: "ORPHA cross-reference row: MONDO:0016027 | Exact"
external_assertions:
- name: Orphanet self-limited neonatal epilepsy record
  source: Orphanet
  assertion_type: structured_disease_record
  external_id: ORPHA:1949
  url: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=1949
  description: >-
    Orphanet identifies self-limited (familial) neonatal epilepsy (a synonym of
    benign familial neonatal seizures) as ORPHA:1949 and provides an exact
    cross-reference to MONDO:0016027.
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "MONDO:0016027 | Exact"
    explanation: Orphanet's cross-reference table maps ORPHA:1949 exactly to MONDO:0016027.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "OMIM:121200 | Exact"
    explanation: Orphanet also provides an exact OMIM cross-reference for benign familial neonatal seizures.
inheritance:
- name: Autosomal dominant
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >-
    Benign familial neonatal seizures segregate in an autosomal dominant manner
    in multigenerational families with heterozygous KCNQ2 or KCNQ3 variants.
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Autosomal dominant"
    explanation: Orphanet directly lists autosomal dominant inheritance for ORPHA:1949.
  - reference: PMID:9425895
    reference_title: "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "One type is benign familial neonatal convulsions (BFNC), a dominantly inherited disorder of newborns."
    explanation: The original KCNQ2 discovery paper characterizes BFNC as a dominantly inherited disorder of newborns.
has_subtypes:
- name: KCNQ2-BFNS
  display_name: KCNQ2-related benign familial neonatal seizures
  description: >-
    The more common molecular subtype, caused by heterozygous loss-of-function
    variants in KCNQ2 on chromosome 20q13.3. Distinct from the more severe
    KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE).
  subtype_term:
    preferred_term: seizures, benign familial neonatal, 1
    term:
      id: MONDO:0007365
      label: seizures, benign familial neonatal, 1
  evidence:
  - reference: PMID:9425895
    reference_title: "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We have identified a sub-microscopic deletion of chromosome 20q13.3 that co-segregates with seizures in a BFNC family."
    explanation: Singh et al. 1998 maps the KCNQ2-BFNC locus to chromosome 20q13.3.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "KCNQ2 | potassium voltage-gated channel subfamily Q member 2 | hgnc:6296 | Disease-causing germline mutation(s) in"
    explanation: Orphanet identifies KCNQ2 as a disease-causing gene for self-limited neonatal epilepsy.
- name: KCNQ3-BFNS
  display_name: KCNQ3-related benign familial neonatal seizures
  description: >-
    The less common molecular subtype, caused by heterozygous variants in
    KCNQ3 on chromosome 8q24.
  subtype_term:
    preferred_term: seizures, benign familial neonatal, 2
    term:
      id: MONDO:0007366
      label: seizures, benign familial neonatal, 2
  evidence:
  - reference: PMID:9425900
    reference_title: "A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
    explanation: Charlier et al. 1998 identifies a KCNQ3 pore-region missense variant co-segregating with BFNC.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "KCNQ3 | potassium voltage-gated channel subfamily Q member 3 | hgnc:6297 | Disease-causing germline mutation(s) in"
    explanation: Orphanet identifies KCNQ3 as a disease-causing gene for self-limited neonatal epilepsy.
progression:
- phase: Neonatal seizure onset
  age_range: First week of life
  notes: >-
    Seizures characteristically begin in the first days to first week of life
    in an otherwise well-appearing term infant.
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Age of onset: Neonatal"
    explanation: Orphanet's natural-history section classifies onset as neonatal.
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "autosomal dominant disorders characterized by neonatal- or infantile-onset focal motor seizures and the absence of neurodevelopmental complications."
    explanation: The ILAE Genetics Commission review summarizes neonatal/infantile onset of focal motor seizures.
- phase: Spontaneous remission
  age_range: Within first year of life
  notes: >-
    Seizures characteristically remit during infancy or early childhood, hence
    the "self-limited" designation; long-term neurodevelopment is generally
    normal.
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "seizures onset typically in the first week of life, in otherwise healthy newborns, and usually resolving within the first year of life."
    explanation: Orphanet definition supports first-week onset and resolution within the first year.
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'Seizures tend to remit during infancy or early childhood and are therefore called "self-limited".'
    explanation: ILAE literacy review supports spontaneous remission in infancy/early childhood.
genetic:
- name: KCNQ2
  association: Causal loss-of-function variant
  gene_term:
    preferred_term: KCNQ2
    term:
      id: hgnc:6296
      label: KCNQ2
  notes: >-
    KCNQ2 encodes the Kv7.2 voltage-gated potassium channel subunit on
    chromosome 20q13. Heterozygous loss-of-function variants are the most common
    cause of benign familial neonatal seizures. Distinct, typically
    dominant-negative variants in KCNQ2 cause the more severe KCNQ2-related
    developmental and epileptic encephalopathy (KCNQ2-DEE).
  inheritance:
  - name: Autosomal dominant with incomplete penetrance
    inheritance_term:
      preferred_term: Autosomal dominant inheritance
      term:
        id: HP:0000006
        label: Autosomal dominant inheritance
    penetrance: INCOMPLETE
    description: >-
      KCNQ2-related benign familial neonatal seizures show autosomal dominant
      inheritance with incomplete penetrance; de novo variants are also
      reported.
    evidence:
    - reference: PMID:36939707
      reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "incomplete penetrance and de novo inheritance occur"
      explanation: The ILAE Genetics Commission review documents incomplete penetrance and de novo inheritance in self-limited familial neonatal/infantile epilepsies, which encompasses KCNQ2-related BFNS.
  evidence:
  - reference: PMID:9425895
    reference_title: "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Five other BFNC probands were shown to have KCNQ2 mutations, including two transmembrane missense mutations, two frameshifts and one splice-site mutation."
    explanation: Singh et al. 1998 established KCNQ2 as the major causal gene for benign familial neonatal convulsions.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "KCNQ2 | potassium voltage-gated channel subfamily Q member 2 | hgnc:6296 | Disease-causing germline mutation(s) in"
    explanation: Orphanet gene table confirms KCNQ2 as a disease-causing gene.
- name: KCNQ3
  association: Causal loss-of-function variant
  gene_term:
    preferred_term: KCNQ3
    term:
      id: hgnc:6297
      label: KCNQ3
  notes: >-
    KCNQ3 encodes the Kv7.3 voltage-gated potassium channel subunit on
    chromosome 8q24, which heteromultimerizes with Kv7.2 to form the neuronal
    M-channel. Heterozygous variants in KCNQ3 are a less common cause of
    benign familial neonatal seizures.
  inheritance:
  - name: Autosomal dominant with incomplete penetrance
    inheritance_term:
      preferred_term: Autosomal dominant inheritance
      term:
        id: HP:0000006
        label: Autosomal dominant inheritance
    penetrance: INCOMPLETE
    description: >-
      KCNQ3-related benign familial neonatal seizures show autosomal dominant
      inheritance with incomplete penetrance; de novo variants are also
      reported.
    evidence:
    - reference: PMID:36939707
      reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "incomplete penetrance and de novo inheritance occur"
      explanation: The ILAE Genetics Commission review documents incomplete penetrance and de novo inheritance in self-limited familial neonatal/infantile epilepsies, which encompasses KCNQ3-related BFNS.
  evidence:
  - reference: PMID:9425900
    reference_title: "A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We screened KCNQ3 for mutations in the large BFNC family previously linked to chromosome 8q24 in the same marker interval. We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
    explanation: Charlier et al. 1998 established KCNQ3 as a causal BFNC gene.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "KCNQ3 | potassium voltage-gated channel subfamily Q member 3 | hgnc:6297 | Disease-causing germline mutation(s) in"
    explanation: Orphanet gene table confirms KCNQ3 as a disease-causing gene.
pathophysiology:
- name: KCNQ2/KCNQ3 K+ Channel Loss-of-Function and M-Current Attenuation
  description: >-
    KCNQ2 (Kv7.2) and KCNQ3 (Kv7.3) subunits heteromultimerize to form the
    neuronal M-channel, a voltage-gated potassium channel that carries the
    slowly activating, non-inactivating M-current. The M-current acts in the
    subthreshold voltage range to dampen repetitive firing and constrain
    neuronal excitability. Heterozygous loss-of-function variants in KCNQ2 or
    KCNQ3 reduce M-current density.
  role: central_effector
  genes:
  - preferred_term: KCNQ2
    term:
      id: hgnc:6296
      label: KCNQ2
  - preferred_term: KCNQ3
    term:
      id: hgnc:6297
      label: KCNQ3
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  - preferred_term: pyramidal neuron
    term:
      id: CL:0000598
      label: pyramidal neuron
  biological_processes:
  - preferred_term: membrane repolarization
    term:
      id: GO:0086009
      label: membrane repolarization
    modifier: DECREASED
  molecular_functions:
  - preferred_term: voltage-gated potassium channel activity
    term:
      id: GO:0005249
      label: voltage-gated potassium channel activity
    modifier: DECREASED
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  evidence:
  - reference: PMID:9836639
    reference_title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "It is concluded that both these subunits contribute to the native M-current."
    explanation: Wang et al. 1998 directly demonstrates that KCNQ2 and KCNQ3 subunits constitute the M-channel.
  - reference: PMID:9836639
    reference_title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The M-current regulates the subthreshold electrical excitability of many neurons, determining their firing properties and responsiveness to synaptic input."
    explanation: Establishes the role of the KCNQ2/3-mediated M-current in regulating subthreshold neuronal excitability.
  - reference: PMID:9425895
    reference_title: "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This finding in BFNC provides additional evidence that defects in potassium channels are involved in the mammalian epilepsy phenotype."
    explanation: The original KCNQ2-BFNC paper directly attributes the phenotype to potassium-channel dysfunction.
  downstream:
  - target: Neonatal Neuronal Hyperexcitability
    causal_link_type: DIRECT
    description: >-
      Reduced M-current decreases subthreshold K+ conductance and lowers the
      threshold for repetitive firing in neonatal cortical neurons, producing
      transient network hyperexcitability.
    evidence:
    - reference: PMID:9836639
      reference_title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "The M-current regulates the subthreshold electrical excitability of many neurons, determining their firing properties and responsiveness to synaptic input."
      explanation: M-current attenuation is the established mechanistic link from KCNQ2/3 loss-of-function to altered subthreshold excitability.
- name: Neonatal Neuronal Hyperexcitability
  description: >-
    Reduced M-current produces a mild, developmentally restricted state of
    cortical hyperexcitability that manifests as focal neonatal seizures.
    Because compensatory potassium conductances and inhibitory circuits mature
    over the first months of life, the hyperexcitability is transient and
    seizures spontaneously remit, distinguishing this benign phenotype from
    KCNQ2-related developmental and epileptic encephalopathy.
  role: downstream_phenotype
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  - preferred_term: pyramidal neuron
    term:
      id: CL:0000598
      label: pyramidal neuron
  biological_processes:
  - preferred_term: neuronal action potential
    term:
      id: GO:0019228
      label: neuronal action potential
    modifier: INCREASED
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  evidence:
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'Seizures tend to remit during infancy or early childhood and are therefore called "self-limited".'
    explanation: The ILAE review confirms the transient, age-limited nature of the seizure phenotype.
  downstream:
  - target: Focal-onset seizures
    causal_link_type: DIRECT
    description: Network-level hyperexcitability manifests as focal neonatal seizures.
    evidence:
    - reference: PMID:28926830
      reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation."
      explanation: Newborns with KCNQ2 variants showed stereotyped focal seizures in the early neonatal period.
phenotypes:
- category: Neurologic
  name: Neonatal Seizure
  description: >-
    Seizures with neonatal onset are the defining clinical feature; first
    seizures typically occur within the first week of life.
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Neonatal seizure
    term:
      id: HP:0032807
      label: Neonatal seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0032807 | Neonatal seizure | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies neonatal seizures as very frequent.
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "autosomal dominant disorders characterized by neonatal- or infantile-onset focal motor seizures and the absence of neurodevelopmental complications."
    explanation: ILAE review supports neonatal-onset focal motor seizures as the defining feature.
- category: Neurologic
  name: Focal-onset Seizure
  description: >-
    Seizures are typically focal in onset, often with tonic or clonic motor
    features and may secondarily generalize.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Focal-onset seizure
    term:
      id: HP:0007359
      label: Focal-onset seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0007359 | Focal-onset seizure | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies focal-onset seizures as very frequent.
- category: Neurologic
  name: Focal Tonic Seizure
  description: >-
    Brief focal tonic seizures, often with apnea and desaturation, are a
    characteristic ictal semiology in KCNQ2/KCNQ3 neonatal epilepsy.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Focal tonic seizure
    term:
      id: HP:0011167
      label: Focal tonic seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0011167 | Focal tonic seizure | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies focal tonic seizures as very frequent.
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation."
    explanation: KCNQ2 case series describes characteristic tonic seizures with apnea/desaturation.
- category: Neurologic
  name: Focal Clonic Seizure
  description: >-
    Focal clonic seizures, classically migrating between limbs and hemispheres,
    are commonly observed.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Focal clonic seizure
    term:
      id: HP:0002266
      label: Focal clonic seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0002266 | Focal clonic seizure | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies focal clonic seizures as very frequent.
- category: Neurologic
  name: Apnea
  description: >-
    Apnea and cyanosis frequently accompany ictal events in neonatal KCNQ2/3
    epilepsy.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Apnea
    term:
      id: HP:0002104
      label: Apnea
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0002104 | Apnea | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies apnea as frequent.
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation."
    explanation: KCNQ2 case series documents ictal apnea as a recurrent feature.
- category: Neurologic
  name: Clonus
  description: >-
    Clonic motor features occur at frequent rate in neonates with KCNQ2/KCNQ3-related
    epilepsy.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Clonus
    term:
      id: HP:0002169
      label: Clonus
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0002169 | Clonus | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies clonus as frequent.
- category: Neurologic
  name: Generalized Tonic Seizure
  description: >-
    Tonic seizures with secondary generalization occur at frequent rate in neonates
    with KCNQ2/KCNQ3-related epilepsy, distinct from the focal tonic semiology that
    dominates initial presentations.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Generalized tonic seizure
    term:
      id: HP:0010818
      label: Generalized tonic seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0010818 | Generalized tonic seizure | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies generalized tonic seizures as frequent.
- category: Neurologic
  name: Focal Autonomic Seizure
  description: >-
    Focal seizures with autonomic features (e.g., apnea, cyanosis, heart-rate
    changes) occur at frequent rate in KCNQ2/KCNQ3-related neonatal epilepsy.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Focal autonomic seizure
    term:
      id: HP:0011154
      label: Focal autonomic seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0011154 | Focal autonomic seizure | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies focal autonomic seizures as frequent.
- category: Neurologic
  name: Circumoral Cyanosis
  description: >-
    Circumoral cyanosis accompanies ictal events at frequent rate, reflecting
    apneic and autonomic involvement in KCNQ2/KCNQ3-related neonatal seizures.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Circumoral cyanosis
    term:
      id: HP:0032556
      label: Circumoral cyanosis
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0032556 | Circumoral cyanosis | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies circumoral cyanosis as frequent.
- category: Neurologic
  name: Limb Myoclonus
  description: >-
    Myoclonic jerks of the limbs occur at frequent rate in neonates with
    KCNQ2/KCNQ3-related epilepsy, distinct from focal clonic semiology.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Limb myoclonus
    term:
      id: HP:0045084
      label: Limb myoclonus
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0045084 | Limb myoclonus | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies limb myoclonus as frequent.
- category: Neurologic
  name: Focal EEG Discharges with Secondary Generalization
  description: >-
    Ictal EEG typically shows focal discharges that can secondarily generalize.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Focal EEG discharges with secondary generalization
    term:
      id: HP:0011188
      label: Focal EEG discharges with secondary generalization
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy (Orphanet structured-database record)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0011188 | Focal EEG discharges with secondary generalization | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies this EEG pattern as very frequent.
diagnosis:
- name: KCNQ2/KCNQ3 molecular genetic testing
  description: >-
    Targeted KCNQ2/KCNQ3 sequencing or epilepsy gene-panel/whole-exome
    sequencing identifies pathogenic variants and confirms the diagnosis.
    Family history of self-limited neonatal seizures strongly supports the
    indication for testing.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: MAXO:0000533
      label: molecular genetic testing
  results: Heterozygous pathogenic or likely pathogenic variants in KCNQ2 or KCNQ3 support the diagnosis.
  evidence:
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we describe important clues in recognition of these syndromes, diagnostic steps including genetic testing, management, and genetic counseling."
    explanation: ILAE Genetics Commission supports genetic testing as part of the diagnostic workup.
- name: Amplitude-integrated EEG (aEEG)
  description: >-
    Amplitude-integrated EEG can capture a distinctive ictal pattern in
    neonates with KCNQ2/3 variants, allowing early recognition and targeted
    therapy before molecular results return.
  results: A distinctive ictal aEEG pattern supports early use of carbamazepine while awaiting genetic confirmation.
  evidence:
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A distinct aEEG seizure pattern, consisting of a sudden rise of the lower and upper margin of the aEEG, followed by a marked depression of the aEEG amplitude, was found in 8 of the 9 patients."
    explanation: Multicenter case series defines a distinctive aEEG pattern in KCNQ2-related neonatal epilepsy.
  - reference: PMID:37827512
    reference_title: "Distinctive Amplitude-Integrated EEG Ictal Pattern and Targeted Therapy with Carbamazepine in KCNQ2 and KCNQ3 Neonatal Epilepsy: A Case Series."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Recognition of the distinctive ictal aEEG pattern in the NICU allowed early and effective targeted therapy with CBZ in four neonates, well before genetic results became available."
    explanation: A subsequent case series confirms aEEG pattern recognition enables early targeted therapy.
treatments:
- name: Carbamazepine
  description: >-
    Carbamazepine, a sodium-channel-blocking antiseizure medication, is
    effective for KCNQ2/KCNQ3-related neonatal seizures and is recommended as
    first- or second-line targeted therapy in this group.
  treatment_term:
    preferred_term: anticonvulsant agent therapy
    term:
      id: MAXO:0000167
      label: anticonvulsant agent therapy
    therapeutic_agent:
    - preferred_term: carbamazepine
      term:
        id: CHEBI:3387
        label: carbamazepine
  target_phenotypes:
  - preferred_term: Neonatal seizure
    term:
      id: HP:0032807
      label: Neonatal seizure
  - preferred_term: Focal-onset seizure
    term:
      id: HP:0007359
      label: Focal-onset seizure
  target_mechanisms:
  - target: Neonatal Neuronal Hyperexcitability
    treatment_effect: INHIBITS
    description: >-
      Sodium-channel blockade by carbamazepine attenuates the action-potential
      bursting that arises from reduced M-current and aborts focal neonatal
      seizures.
    evidence:
    - reference: PMID:37827512
      reference_title: "Distinctive Amplitude-Integrated EEG Ictal Pattern and Targeted Therapy with Carbamazepine in KCNQ2 and KCNQ3 Neonatal Epilepsy: A Case Series."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Carbamazepine (CBZ) is effective in treating KCNQ2/3-related seizures, which may present with a distinctive amplitude-integrated electroencephalography (aEEG) pattern."
      explanation: Case-series evidence supports carbamazepine as effective targeted therapy for KCNQ2/3 neonatal seizures.
  evidence:
  - reference: PMID:37827512
    reference_title: "Distinctive Amplitude-Integrated EEG Ictal Pattern and Targeted Therapy with Carbamazepine in KCNQ2 and KCNQ3 Neonatal Epilepsy: A Case Series."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "prompted the use of CBZ that was effective in all."
    explanation: Carbamazepine was effective in all four neonates given the targeted therapy in this case series.
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Prompt recognition of this pattern led to early treatment with carbamazepine in the 2 most recent cases."
    explanation: Earlier KCNQ2 case series also supports carbamazepine as targeted therapy.
- name: Sodium-channel-blocking Antiseizure Medication Therapy
  description: >-
    Sodium-channel blockers as a class (e.g., carbamazepine, oxcarbazepine,
    phenytoin) are favored over phenobarbital for KCNQ2/KCNQ3-related neonatal
    seizures based on a precision-medicine approach.
  treatment_term:
    preferred_term: anticonvulsant agent therapy
    term:
      id: MAXO:0000167
      label: anticonvulsant agent therapy
  target_phenotypes:
  - preferred_term: Neonatal seizure
    term:
      id: HP:0032807
      label: Neonatal seizure
  evidence:
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Early recognition of the electroclinical phenotype by using aEEG may direct genetic testing and a precision medicine approach with sodium channel blockers in neonates with KCNQ2 mutations."
    explanation: The case series explicitly recommends sodium-channel blockers as targeted precision therapy in KCNQ2 neonatal epilepsy.
datasets: []
📚

References & Deep Research

Deep Research

1
Manual Pubmed Review ▸
Benign Neonatal Seizures: Manual Deep Research Summary
n/a 6 citations 2026-05-13T13:30:00Z

Benign Neonatal Seizures: Manual Deep Research Summary

Disease-level modeling decision

Benign neonatal seizures is modeled as one disease-level entry covering the autosomal-dominant KCNQ2- and KCNQ3-related forms of self-limited familial neonatal epilepsy. Two molecular subtypes are exposed via has_subtypes, each grounded to the corresponding MONDO term:

  • KCNQ2-BFNS → MONDO:0007365 (seizures, benign familial neonatal, 1; xref OMIM:121200).
  • KCNQ3-BFNS → MONDO:0007366 (seizures, benign familial neonatal, 2; xref OMIM:121201).

The much more severe KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE) is intentionally excluded from this entry — the disease description notes the boundary so future curators do not collapse the two clinical entities.

Inheritance and penetrance

ORPHA:1949 lists autosomal dominant inheritance for self-limited neonatal epilepsy. The original KCNQ2 paper (PMID:9425895) frames the condition as "a dominantly inherited disorder of newborns."

The ILAE Genetic Literacy review (PMID:36939707) is the strongest source for incomplete penetrance and de novo inheritance:

"incomplete penetrance and de novo inheritance occur."

This justifies tagging both KCNQ2 and KCNQ3 Inheritance blocks in the genetic section with penetrance: INCOMPLETE.

Pathophysiology: KCNQ2/KCNQ3 LOF → M-current attenuation → transient neonatal hyperexcitability

The mechanistic chain is documented across the cached literature:

  1. KCNQ2 and KCNQ3 subunits form the neuronal M-channel. PMID:9836639: "It is concluded that both these subunits contribute to the native M-current."
  2. The M-current sets subthreshold excitability. PMID:9836639: "The M-current regulates the subthreshold electrical excitability of many neurons, determining their firing properties and responsiveness to synaptic input."
  3. Heterozygous LOF variants in KCNQ2/3 reduce M-current density and cause BFNC. PMID:9425895: "This finding in BFNC provides additional evidence that defects in potassium channels are involved in the mammalian epilepsy phenotype." PMID:9425900 maps a KCNQ3 pore-region missense variant co-segregating with BFNC.
  4. Network-level hyperexcitability is transient and remits. PMID:36939707: "Seizures tend to remit during infancy or early childhood and are therefore called 'self-limited'."

The disorder YAML therefore exposes two atomic pathophysiology nodes connected by a downstream edge:

  • KCNQ2/KCNQ3 K+ Channel Loss-of-Function and M-Current Attenuation (central_effector) — captures the molecular function (GO:0005249, DECREASED) and process (GO:0086009 membrane repolarization, DECREASED).
  • Neonatal Neuronal Hyperexcitability (downstream_phenotype) — captures the network-level firing increase (GO:0019228 neuronal action potential, INCREASED), localized to cerebral cortex, with a further downstream edge to the clinical Focal-onset Seizure phenotype.

This decomposition deliberately avoids the bundled "channelopathy → seizures" anti-pattern flagged in prior dismech reviews.

Clinical phenotypes

ORPHA:1949 supplies a curated HPO-frequency table that I have mapped directly into the phenotypes block:

  • Neonatal seizure (HP:0032807) — Very frequent (99–80%)
  • Focal-onset seizure (HP:0007359) — Very frequent
  • Focal tonic seizure (HP:0011167) — Very frequent
  • Focal clonic seizure (HP:0002266) — Very frequent
  • Apnea (HP:0002104) — Frequent (79–30%)
  • Focal EEG discharges with secondary generalization (HP:0011188) — Very frequent

PMID:28926830 (the multicenter aEEG case series) supports the focal tonic semiology with characteristic apnea and desaturation.

Diagnosis and targeted therapy

PMID:36939707 supports molecular genetic testing (MAXO:0000533) as part of the diagnostic workup. PMID:28926830 and PMID:37827512 jointly support amplitude-integrated EEG (aEEG) as an early-recognition tool that enables targeted carbamazepine therapy before genetic confirmation:

"Recognition of the distinctive ictal aEEG pattern in the NICU allowed early and effective targeted therapy with CBZ in four neonates, well before genetic results became available." (PMID:37827512)

Carbamazepine (CHEBI:3387) is exposed as a specific treatment using the treatment_term = MAXO:0000167 (anticonvulsant agent therapy) + therapeutic_agent = CHEBI:3387 pattern, with a target_mechanisms link back to the Neonatal Neuronal Hyperexcitability node. The Sodium-channel-blocking Antiseizure Medication Therapy treatment generalizes this to the drug class.

Phenobarbital is recognized in clinical practice as an empiric first-line neonatal antiseizure agent before genetic confirmation, but is intentionally not modeled as a targeted therapy because it does not act on the KCNQ2/3 mechanism; the YAML keeps the mechanistic focus on sodium-channel blockers, per the precision- medicine framing in PMID:28926830.

References used

  • PMID:9425895 — KCNQ2 discovery in BFNC.
  • PMID:9425900 — KCNQ3 pore-region missense in BFNC.
  • PMID:9836639 — KCNQ2/KCNQ3 as molecular correlates of the M-channel.
  • PMID:28926830 — Distinctive ictal aEEG pattern in KCNQ2 neonatal epilepsy; precision medicine with Na+-channel blockers.
  • PMID:36939707 — ILAE Genetic Literacy review of self-limited familial neonatal/infantile epilepsies; incomplete penetrance and de novo inheritance.
  • PMID:37827512 — Carbamazepine targeted therapy guided by aEEG pattern recognition.
  • ORPHA:1949 — Orphanet structured-database record (HPO frequencies, gene-disease table, MONDO/OMIM cross-references, inheritance).